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This report describes the identification of a murine cytomegalovirus (MCMV) G protein-coupled receptor
(GCR) homolog. This open reading frame (M33) is most closely related to, and collinear with, human
cytomegalovirus UL33, and homologs are also present in human herpesvirus 6 and 7 (U12 for both viruses).
Conserved counterparts in the sequenced alpha- or gammaherpesviruses have not been identified to date,
suggesting that these genes encode proteins which are important for the biological characteristics of betaher-
pesviruses. We have detected transcripts for both UL33 and M33 as early as 3 or 4 h postinfection, and these
reappear at late times. In addition, we have identified N-terminal splicing for both the UL33 and M33 RNA
transcripts. For both open reading frames, splicing results in the introduction of amino acids which are highly
conserved among known GCRs. To characterise the function of the M33 in the natural host, two independent
MCMV recombinant viruses were prepared, each of which possesses an M33 open reading frame which has
been disrupted with the b-galactosidase gene. While the recombinant M33 null viruses showed no phenotypic
differences in replication from wild-type MCMV in primary mouse embryo fibroblasts in vitro, they showed
severely restricted growth in the salivary glands of infected mice. These data suggest that M33 plays an
important role in vivo, in particular in the dissemination to or replication in the salivary gland, and provide
the first evidence for the function of a viral GCR homolog in vivo.
Analysis of the complete genome of human cytomegalovirus
(HCMV) several years ago revealed three homologs of cellular
G protein-coupled receptors (GCRs) encoded by the UL33,
US27, and US28 genes (9). Members of this large and diverse
family of receptors function in signal transduction through cell
membranes by activating G proteins and are triggered by small
ligands such as hormones, neurotransmitters, and chemoat-
tractant cytokines (23). It has recently become apparent that
viral homologs of GCRs are not confined to HCMV. GCR
homologs have been identified in poxviruses (6, 22) and in the
following beta- and gammaherpesviruses: murine cytomegalo-
virus (MCMV) (28), human herpesvirus 6 (HHV-6) (15, 27),
human herpesvirus 7 (HHV-7) (25), herpesvirus saimiri (HVS)
(26), and equine herpesvirus 2 (31). Sequence analysis has
indicated that the HVS ECRF3 gene and the HCMV US28
gene are most closely related to GCRs which bind leukocyte
chemoattractant peptides, called chemokines (1, 24). Both
gene products possess a disproportionately high homology with
chemokine receptor N-terminal amino acid sequences, which
have been shown to be involved in ligand binding and/or ligand
localization (14). In agreement with these observations, in vitro
studies demonstrated that cells transfected with either HVS
ECRF3 or HCMV US28 specifically bound alpha or beta che-
mokines, respectively (1, 13, 24). Significantly, ligand binding
to the transfected cells stimulated intracellular calcium mobi-
lization, and while the subsequent activation of second-mes-
senger pathways typical of G protein-mediated signal transduc-
tion responses has not yet been determined, it has been
tempting to suggest that these viral GCR homologs play a role
in cytokine-activated second-messenger systems.
In contrast to US28, analysis of the HCMV UL33 sequence
did not suggest notable homology with chemokine receptors,
due to the lack of conserved features at the N terminus. Sub-
sequently, UL33 was shown to be nonessential in vitro (5), and
the virulence of HCMV recombinant viruses deleted of UL33
was shown to be indistinguishable from that of wild-type
HCMV in the SCID-Hu mouse model (4). Given the lack of
potential candidate ligands for UL33 and the absence of a
phenotype in vitro and in an immunodeficient in vivo model,
there has thus far been no evidence for an important role of
UL33 in the virus life cycle. If UL33 interacts with the host
immune system, it is likely that the effects of deleting this gene
will become apparent only in the context of an intact immune
response.
MCMV has proved a useful model for HCMV disease, since
its pathogenesis closely resembles that of HCMV (17). In ad-
dition, recent analysis of the complete nucleotide sequence of
MCMV (Smith) has revealed a large number of open reading
frames (ORFs) with significant homology to those of HCMV
(28), thus supporting the observed biological similarities be-
tween these viruses. In this paper, we report the characteriza-
tion of the MCMVORFM33, which is conserved and collinear
with HCMV UL33, HHV-6 U12, and HHV-7 U12. Initial
alignment of the M33, UL33, and U12 ORFs showed a low
level of conservation at the N terminus. However, we demon-
strate that both UL33 and M33 are spliced at the N terminus
and that the resulting authentic ORFs show an increased level
of conservation with other mammalian GCRs. Finally, we
present the growth kinetics of two independent MCMV re-
combinants for which the M33 ORF has been disrupted by
insertion of a lacZmarker gene cassette. While dispensable for
growth in fibroblasts in vitro, M33 is required for efficient
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replication in vivo, most notably in the salivary gland. Thus,
this report provides the first direct evidence for the role of a
viral GCR homolog during infection of the natural host.
MATERIALS AND METHODS
Cells. Primary mouse embryo fibroblasts (MEF) and human foreskin fibro-
blasts (HFF) were grown in minimal essential medium (MEM; Gibco) supple-
mented with 10% newborn calf serum (NCS).
Virus. The K181 strain of MCMVwas used in this study. Wild-type and mutant
viruses were propagated and subjected to titer determination on MEF as previ-
ously described (2). For in vivo studies, virus stocks were propagated in 3-week-
old BALB/c mice (2). HCMV (AD169) (provided by Jane Allan, University of
Western Australia) was propagated and subjected to titer determination on
HFF.
Mice. Specific-pathogen-free BALB/c female mice (Animal Resource Centre,
Murdoch, Western Australia) were maintained under minimal disease conditions
for the duration of the studies.
Preparation of MCMV and HCMV DNA. MEF and HFF were infected with
MCMV and HCMV, respectively, at a multiplicity of infection (MOI) of 0.01.
When the cells exhibited an extensive cytopathic effect, infected-cell DNA was
prepared by published methods (20).
Preparation of RNA. For the preparation of MCMV RNA, confluent mono-
layers of MEF were infected with MCMV at an MOI of 5. For immediate-early
RNA, cells were maintained in growth medium containing 30 mg of cyclohexi-
mide per ml and RNA was prepared 4 h postinfection (p.i.). For early RNA,
MEF were maintained in growth medium containing 250 mg of phosphonoacetic
acid (PAA) per ml for 24 h prior to harvest. RNA was prepared from MEF
maintained in the absence of drug treatment at 3 and 24 h p.i. For the prepa-
ration of HCMV RNA, HFF were infected with HCMV (AD169) at an MOI of
5. For early RNA, HFF treated with PAA were harvested at 60 h p.i. RNA was
also harvested at 4, 8, and 60 h p.i. from HFF maintained in the absence of drug
treatment. All RNA was prepared by the method of Chomczynski and Sacchi
(11). Poly(A)1 RNA was purified with oligo(dT)-coupled matrix (QIAGEN) as
specified by the manufacturer.
Northern blot analysis. RNA samples (10 mg) were denatured at 658C for 15
min in 20 mM morpholinepropanesulfonic acid (MOPS; pH 7)–1 mM EDTA–5
mM sodium acetate (MOPS buffer) containing 50% formamide and 2 M form-
aldehyde and then loaded onto 1.5% agarose gels containing 0.66 M formalde-
hyde prepared in MOPS buffer. After electrophoresis, the separated RNA was
transferred to nylon membranes, UV irradiated, and prehybridized in 36%
formamide–75 mM sodium citrate–0.75 M sodium chloride–0.1% bovine serum
albumin–0.1% Ficoll–0.1% polyvinylpyrrolidone–0.1% sodium dodecyl sulfate
(SDS)-50 mM sodium phosphate (pH 6.5)–200 mg of salmon sperm DNA per ml
at 558C overnight. [32P]dCTP-labelled DNA probes were prepared by using a
random prime kit (Bresatec). Radiolabelled probes were then incubated with
prehybridized membranes in 10 ml of hybridization solution (36% formamide, 75
mM sodium citrate, 0.75 M sodium chloride, 0.02% bovine serum albumin,
0.02% Ficoll, 0.02% polyvinylpyrrolidone, 0.1% SDS, 200 mg of salmon sperm
DNA per ml, 10% dextran sulfate) at 558C overnight. The membranes were
washed twice with 23 SSC (13 SSC is 0.15 M NaCl plus 0.015 M sodium
citrate)–0.1% SDS solution (5 min per wash), twice with 0.23 SSC–0.1% SDS
(15 min each wash), and twice with 0.023 SSC–0.1% SDS (15 min each wash).
All washing steps were performed at 658C. The membranes were then exposed to
X-ray film at 2808C with an intensifying screen. Probes were stripped from the
membranes by boiling in a solution of 1% SDS for 15 min. Removal of bound
probe was confirmed by exposure of the membrane to X-ray film.
Synthesis, cloning, and sequencing of M33 and UL33 cDNA. For M33 cDNA,
first-strand synthesis of poly(A)1 selected RNA obtained from MCMV-infected
MEF 2 h p.i. was performed with avian myeloblastosis virus (AMV) reverse
transcriptase (RT) (Promega) and oligonucleotide MR2 (59CCCTCATCCTGT
CATTC39) as the primer (Fig. 1D). Following the reverse transcription reaction,
the cDNA products were diluted 10-fold and the M33 region was amplified by
PCR with oligonucleotide MR1 (59TAGATGCGGTTCGACAG39) paired with
either oligonucleotide MF1 (59GGCTCGAGATGGACGTC39, specific for the
putative 59 exon) or MF2 (59ACATATCTCGCCCTCTC39, specific for the pu-
tative intron). The RT-PCR product was cloned into pGEM-T (Promega), and
four individually cloned products were sequenced by previously described meth-
ods (29). The same approach was used to generate, clone, and sequence HCMV
UL33 cDNA, using RNA from HCMV-infected HFF at 4 h p.i. The cDNA was
generated with oligonucleotide HR2 (59TCATGAGAGAGACGTAGG39) as
FIG. 1. Genetic organization of the region of the MCMV genome encoding the GCR homolog and the specificity of genomic fragments and oligonucleotides used
in these studies. (A) Representation of the MCMV genome (Smith) as a HindIII map. (B) Expansion of the HindIII B region and arrangement of putative ORFs, M32
to M35, which are collinear and homologous with HCMV UL32 to UL35. All ORFs are trimmed to the first ATG. The locations of poly(A) signals are indicated. (C)
Specificity of subgenomic MCMV fragments used as probes for Northern analysis. (D and E) Further expansion of the region encoding the predicted spliced M33 gene
and the specificity of oligonucleotides used for RT-PCR assays (D) and for UL33 of HCMV (E).
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the primer and was amplified with HR1 (59GTAGAGTAGAGGTTGGTC39)
which was paired with HF1 (59GACACCATCATCCACAAC39, specific for the
putative 59 exon) or HF2 (59CCGCTGACTTGTTTCTTC39, specific for the
putative intron) as shown in Fig. 1E.
Plasmid constructs. The derivation of plasmids used in this study is shown
schematically in Fig. 2. Nucleotide positions are given according to the complete
genomic sequence of MCMV (Smith) (28). Plasmid pK181HB (kindly provided
by A. Scalzo, University of Western Australia), which contains the HindIII B
fragment (nucleotides [nt] 35844 to 62239) of MCMV (K181) cloned into
pGEM11Zf was used in this study. A 4.96-kb BglII fragment (nt 39402 to 44366)
of pK181HB, which contains the M33 ORF (nt 41794 to 42777) together with
flanking sequence, was subcloned between the BamHI and BglII sites of
pING14.2 (19) to generate plasmid pINGM33. A 3.8-kb blunt-ended b-galacto-
sidase expression cassette, encoding the lacZ gene flanked by the HCMV IE1
promoter and poly(A) signals, was derived from pMV10 (12) by digestion with
HindIII followed by a Klenow fill-in reaction. Two recombination plasmids were
constructed by insertion of the b-galactosidase cassette within the M33 ORF at
two different sites. For pM33ZE, the cassette was inserted into the EcoRV site
(nt 41618, located in the putative intron), and for pM33ZB, insertion occurred at
a BstEII site (nt 41977, downstream of the putative splice acceptor site), which
had been blunt ended by a Klenow fill-in reaction.
Transfection. Transfection of MEF was performed on subconfluent monolay-
ers (35-mm dishes) by the modified calcium phosphate procedure of Chen and
Okayama (10). Monolayers were transfected with 10 mg of MCMV (K181)-
infected cell DNA plus 3 to 6 mg of the plasmid DNA of interest. At 16 to 20 h
posttransfection, the monolayers were washed with MEM and fresh MEM–10%
NCS was added. After a further 4 to 6 days of incubation, dishes were frozen
(2808C) and thawed and the contents were sonicated and stored as aliquots at
2808C. Transfection stocks were subjected to titer determination on MEF and
incubated for 4 days under a MEM–2% NCS–0.7% carboxymethyl cellulose
overlay, and the frequency of recombinant plaques was determined by fixing with
glutaraldehyde and staining with 5-bromo-4-chloro-3-indolyl-b-D-galactopyrano-
side (X-Gal) as described previously (12). Transfection stocks with a recombi-
nation frequency of $0.05% were used to select cloned recombinant viruses as
follows. Stocks were plated onto MEF at an appropriate density to allow picking
of individual plaques. After 4 days of incubation, the overlay was removed and
replaced with fresh overlay supplemented with 50 mg of X-Gal per ml. Blue
plaques, visible after 1 to 3 h of incubation, were picked and stored in 1 ml of
MEM–10% NCS at 2808C. Plaque samples were subsequently thawed, soni-
cated, and subjected to titer determination (using centrifugal enhancement), and
recombinant plaques were identified and picked as described above. Each re-
combinant was selected by three rounds of plaque purification prior to confir-
mation of the recombination by Southern blotting.
Southern blot analysis. Infected-cell DNA was prepared from wild-type- or
recombinant-infected MEF. The DNA was digested with EcoRI, and 2 mg of
each sample was separated on a 0.8% agarose and transferred to nylon mem-
branes by standard methods (20). The probes used, specific for the M33 region
or lacZ cassette, were the 4.9-kb BglII fragment of pK181HB and the 3.8-kb
HindIII fragment of pMV10 (described above), respectively. DNA fragments
were gel purified prior to radiolabelling (Bresatec GigaPrime kit) and use in
hybridization experiments as specified by the manufacturer.
In vitro growth of MCMV DM33 mutants. Multistep growth curves were
determined for wild-type and mutant viruses in MEF. Cells were infected at an
MOI of 0.01 for 1 h at 378C. Following adsorption, the monolayers were washed
with MEM, overlaid with MEM–2%NCS, and incubated for various times prior
to harvest. Wells were harvested by freezing (2808C) and thawed, and aliquots
were stored at 2808C prior to titer determination on MEF monolayers.
In vivo growth of MCMV DM33 mutants.Mice were inoculated with wild-type
MCMV or mutant viruses by the intraperitoneal route unless otherwise indi-
cated. At the designated times p.i., the animals were sacrificed and salivary
glands and/or livers and spleens were removed. All organs were individually
weighed, homogenized in MEM–2% NCS, and centrifuged at 2,000 3 g. The
supernatant was stored at 2808C and subsequently subjected to titer determi-
nation on MEF. At least three to five mice per group per time point were
assessed for each virus. Parental (wild-type) MCMV was included in each ex-
periment as a control.
Nucleotide sequence accession number. The sequence of the M33 spliced gene
of MCMV has GenBank accession number L41868.
RESULTS
Sequence analysis of MCMV M33. MCMV encodes a GCR
homolog (designated M33) which is most closely related to,
and collinear with, the HCMV UL33 (47% identity), HHV-6
U12 (28% identity), and HHV-7 U12 (29% identity) ORFs.
The position and orientation of genes flanking M33 (all of
which are conserved and collinear with HCMV) and the loca-
tion of putative poly(A) sequences are shown in Fig. 1A and B.
At the nucleotide level, M33 is similar to UL33 in that it lacks
a consensus TATA promoter element and a proximal 39
poly(A) signal. The M33 ORF encodes a polypeptide which
possesses characteristic features of the GCR family, which
FIG. 2. Construction diagrams (not drawn to scale) for plasmids used in this study. Where appropriate, nucleotide positions are indicated according to the complete
nucleotide sequence of MCMV (Smith). Additional details are given in the text.
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include the presence of multiple membrane-spanning domains,
the conservation of specific motifs in transmembrane domains
II and VII, the presence of two highly conserved cysteine
residues in the second and third extracellular domains, and a
serine/threonine-rich C terminus. However, the N-terminal
amino acid sequence (spanning the predicted first extracellular
domain) is missing in M33 and is truncated in UL33 and
HHV-6 U12 in comparison with the protein sequences of the
majority of mammalian and viral GCRs. Furthermore, the N
termini predicted for the ORFs M33, UL33, and HHV-6 U12
are unusual in that they all lack N-linked glycosylation sites,
unlike the majority of known GCRs. As described below, these
anomalies can be resolved by splicing near the 59 end of these
transcripts, resulting in altered N-terminal sequences.
Transcriptional analysis of the M33 region. To characterize
the expression of the M33 ORF during MCMV infection, the
transcripts produced from the M33 region were identified by
Northern blot analysis and the kinetic class of the transcripts
was determined.
In the following description, nucleotide positions are listed
according to the MCMV genomic sequence (28). Probe frag-
ments were derived from pINGM33 (Fig. 2), and their posi-
tions are indicated in Fig. 1C. A 4.5-kb transcript was detected
at 3 h p.i. with the M33-specific NruI fragment (nt 41741 to
43176), and lower levels of this transcript were also detected at
late times (Fig. 3A). This transcript could not be detected at
24 h p.i. in the presence of PAA, indicating that transcription
of M33 is downregulated at late times in the absence of DNA
replication. Moreover, the transcript could not be detected in
cells infected in the presence of cycloheximide and harvested
3 h p.i. (data not shown), indicating that M33 is not expressed
as an immediate-early gene. The 4.5-kb transcript is consistent
in size with an RNA reading through both M33 and M34 ORFs
and terminating at the first poly(A) signal 39 of M34. An
additional 5.5-kb transcript was detected at 24 h p.i. To confirm
that the 4.5-kb transcript encodes sequences from both M33
and M34 and to determine whether the 5.5-kb transcript in-
cludes sequences upstream or downstream of M33, transcripts
arising from the adjacent M34 and M32 ORFs were detected
with the PvuI (nt 43458 to 43901) and HincII (nt 40025 to
40624) fragments as probes, respectively (Fig. 1C). The PvuI
probe detected a 3.4-kb transcript (consistent with the ex-
pected size of the M34 transcript) at 3 and 24 h p.i. and an
additional 4.5-kb transcript at 3 h p.i. (Fig. 3B). On a longer
exposure than displayed in Fig. 3B, the 4.5- and 5.5-kb tran-
scripts observed with the NruI probe at 24 h p.i. were also
detected with the PvuI probe (data not shown). These data
support the above proposal that the 4.5-kb transcript includes
sequences from M33 and M34 and is therefore similar to
HCMV UL33, which is expressed as a 39 coterminal transcript
with UL34 (22). The presence of transcripts initiating up-
stream of the M33 intron and continuing through the M34
ORF has been confirmed by RT-PCR analyses (data not
shown). The HincII probe detected an abundant 2.1- to 2.4-kb
late transcript, consistent with the size of M32 (Fig. 3C). Al-
though the the M32 ORF possesses an internal poly(A) signal,
this is unlikely to be utilized, given that it is a considerable
distance (228 bp) upstream of the stop codon and is not fol-
lowed by a GT-rich tract characteristic of transcription poly(A)
signals (3). An alternative poly(A) signal (AGTAAA), which is
61 bp downstream of the M32 stop codon and is followed
closely by a GT-rich tract, is more likely to be utilized. None of
the probes reacted with RNA from uninfected MEF, indicating
that the transcripts were specific for MCMV-infected RNA.
Temporal expression of the HCMV UL33 transcript. Previ-
ous studies of the three HCMV GCR transcripts (34) sug-
FIG. 3. Northern blot analysis of RNA isolated from MCMV-infected MEF
(A to C) and HCMV-infected HFF (D). The time p.i. at which the RNA was
harvested is shown above each lane; 0 h p.i. refers to uninfected cultures. Total
RNA (10 mg) was separated in a denaturing agarose gel, blotted onto nylon, and
hybridized with double-stranded DNA probes specific for either M33 (A), M34
(B), M32 (C), or UL33 (D) as described in the text. Transcript sizes were
determined relative to RNA markers (Promega). The locations of 28S and 18S
rRNA are indicated.
FIG. 4. Evidence for N-terminal splicing in MCMV M33 and HCMV UL33
genes. RT-PCRs of poly(A)1 RNA from MCMV-infected MEF (3 h p.i.) or
HCMV-infected HFF (4 h p.i.) were performed with oligonucleotides whose
specificity is shown in Fig. 1D and E. First-strand synthesis with AMV-RT was
performed by using oligonucleotide MR2 (for MCMV) or HR2 (for HCMV).
Amplification of RT products by PCR was performed with the following oligo-
nucleotide pairs: MF1/MR1 (lane 3) or MF2/MR1 (lane 4) for MCMV and
HF1/HR1 (lane 9) or HF2/HR1 (lane 10) for HCMV. The same primer pairs
were used to amplify viral genomic DNA by direct PCR, MF1-MR1 (lane 1),
MF2-MR1 (lane 2), HF1-HR1 (lane 7), and HF2-HR2 (lane 8). To confirm that
the amplified RT products were derived from RNA rather than from contami-
nating genomic DNA, control RT reactions were carried out in the absence of
AMVRT (lanes 5, 6, 11, and 12). Products were separated on a 2.7% agarose gel.
The relative migrations of molecular weight markers (in base pairs) are indicated
in lanes M. No products were observed in uninfected cultures (not shown).
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gested that they were all expressed at late times p.i. and could
not be detected from cells which had been maintained for 7
days p.i. in medium containing phosphonoformic acid, a viral
DNA synthesis inhibitor. Following our observation that the
M33 transcript could not be detected when DNA synthesis was
blocked, despite being expressed from early times p.i., we in-
vestigated the expression of the UL33 transcript in HCMV-
infected human HFF. Northern blot analysis was performed as
described in Materials and Methods, using a double-stranded
DNA probe specific for the complete UL33 ORF (a gift from
Helena Browne, University of Cambridge). A 3.3-kb transcript
(visible as a faint band in Fig. 3D) was detected at 4 and 8 h p.i.
and again (more strongly) at late times p.i., consistent with an
RNA reading through both UL33 and UL34 ORFs, terminat-
ing at the first poly(A) signal downstream of UL34 (Fig. 3D).
These results are similar to those observed for M33, except
that maximal detection of UL33 occurs at late rather than early
times p.i. Similar to M33, no transcript was detected at 4 h p.i.
in the presence of cycloheximide (data not shown). No tran-
script was detected at 60 h p.i. in the presence of PAA, which
is consistent with the results of Welch et al. (34). Unlike the
previous report, however, we conclude that UL33 expression
does occur at early times prior to DNA replication. Additional
evidence for expression of UL33 at early times p.i. was ob-
tained by RT-PCR analysis as described below.
Both MCMV M33 and HCMV UL33 are expressed as
spliced transcripts. Further inspection of the amino acid se-
quence alignment of M33 with UL33 showed that a significant
level of conservation was maintained upstream of the first start
codon in M33, suggesting that M33 may be expressed as a
spliced transcript. Putative splice donor and acceptor sites
were identified 286 and 114 bp upstream of the ATG, respec-
tively. This arrangement results in a short 59 exon, encoding an
ATG followed by 10 codons, which is separated from the
remainder of the ORF by a 161-bp intron. To test the existence
of this splice, RT-PCR was performed with poly(A)1 RNA
from infected (3 h p.i.) MEF as the template and oligonucle-
otides specific for either the putative exon or intron sequences
(Fig. 1D). For both primer pairs, PCR products of the pre-
dicted size were generated with MCMV-infected cell DNA as
a template (Fig. 4, lanes 1 and 2). In contrast, an RT-PCR
product was observed only in reactions amplified with the
MF1-MR1 primer pair, and this product was approximately
160 bp shorter than the corresponding PCR product amplified
from viral DNA, consistent with the predicted splice (lane 3).
In control reactions performed as above but without the addi-
tion of AMV RT (lanes 5 and 6), no amplified products were
observed, confirming that the RT-PCR products were derived
from RNA transcripts rather than contaminating DNA. In
addition, products of the same size were amplified from cDNA
generated from oligo d(T)15-primed RT reactions (data not
shown). No products were observed with RNA from unin-
fected MEF (data not shown).
A similar splicing pattern for HCMV UL33 was also pre-
dicted on the basis of the identification of splice donor and
acceptor sites 164 and 42 bp upstream of the published ATG,
respectively. This arrangement results in a 59 exon, encoding
an ATG followed by seven codons, separated from rest of the
ORF by a 121-bp intron. By using the same experimental
approach as used to show the M33 splice, RT-PCR was per-
formed with poly(A)1 selected RNA from HCMV-infected (4
h p.i.) HFF as the template and oligonucleotides specific for
the predicted exon and intron sequences (Fig. 1E). For both
primer pairs, PCR products of the predicted size were gener-
ated with HCMV infected-cell DNA as the template (Fig. 4,
lanes 7 and 8). By using the HF1-HR1 primer pair, an RT-PCR
product approximately 120 bp shorter than the corresponding
PCR product amplified from viral DNA was observed (lane 9),
consistent with the predicted splice. By using the HF2-HR1
primer pair, a faint RT/PCR product can be observed, indicat-
ing that a proportion of the UL33 transcript is unspliced (lane
10). No products were amplified from reactions performed in
the absence of AMV RT, confirming that the observed RT-
PCR products were derived from RNA (lanes 11 and 12).
FIG. 5. Nucleotide sequence of the splice junction determined for MCMV M33 (A) and HCMV UL33 (B) or predicted for HHV-6 U12 and HHV-7 U12. The
nucleotide sequences upstream and downstream of the splice sites are shown, with the predicted amino acid sequences shown above. The intron sequences are displayed
in lowercase type. The initiating ATGs previously predicted for the unspliced ORFs are underlined.
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The M33 and UL33 RT-PCR products were cloned into
pGEM-T (Promega) and sequenced on both strands by using
forward and reverse universal primers and fluorescent dye
terminators on an automated sequencer (Applied Biosystems).
At least four individual clones were sequenced for each RT-
PCR product. Sequencing of these products confirmed the
existence of the spliced mRNA, and the identified splice junc-
tions and intron sequences are shown in Fig. 5A and B. In-
spection of the HHV-6 U12 sequence identified similar splice
donor and acceptor sites upstream of the previously published
ATG (15), and putative splice donor/acceptor sites are simi-
larly present in the HHV-7 U12 sequence (25); the predicted
exon and intron sequences should these sites be utilized are
shown in Fig. 5C and D. Figure 6A shows an alignment of the
authentic M33 and UL33 amino acid sequences with the pre-
dicted spliced U12 genes of HHV-6 and HHV-7. The pre-
dicted topology and conserved features characteristic of che-
mokine receptors noted from this alignment are displayed in
Fig. 6B and are further described in Discussion.
Construction of MCMV recombinants with disrupted M33.
To investigate the biological significance of M33, MCMV re-
combinants in which the M33 coding region had been dis-
rupted by insertion of a lacZ expression cassette were pro-
duced. Two separate insertion sites were used, as shown in Fig.
2, and the resulting recombinants were designated KD33E
(disrupted at an EcoRV site) and KD33B (disrupted at a
BstEII site), with subscripts indicating independent recombi-
nants (e.g., KD33BT2, KD33BT8). Recombinant plaques were
FIG. 6. (A) Multiple alignment of the betaherpesvirus GCR homologs compiled with Clustalw (33). Amino acids conserved among the four sequences are indicated
by p (identical) and I (similar). The predicted extracellular (E), transmembrane (TM), and cytoplasmic (C) regions are indicated above the aligned sequences and
numbered sequentially from the N terminus with Roman numerals. The positions of amino acids flanking the splice junctions identified (MCMV and HCMV) or
predicted (HHV-6 and HHV-7) near the N terminus of each of the sequences are singly underlined. Features conserved with chemokine receptors are indicated by
double underlining (potential N-linked glycosylation site) or in boldface type (specific amino acid residues). (B) Diagrammatic representation of the predicted topology
for the GCR receptor homologs, highlighting features characteristic of chemokine receptors (adapted from reference 23).
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identified following cotransfection of viral and plasmid DNA
as blue plaques in the presence of X-Gal (see Materials and
Methods). Following three rounds of plaque purification,
stocks of each recombinant were prepared and virus-infected
cell DNA was analyzed by restriction enzyme digestion fol-
lowed by Southern blot hybridization. Figure 7 shows the result
of this analysis for KD33BT2 and KD33E, in comparison with
wild-type K181. All samples were digested with EcoRI and
hybridized to probes specific for either the M33 region (Fig.
7A) or the lacZ cassette (Fig. 7B). The bands observed for both
recombinants are as predicted following correct insertion of
the lacZ cassette, and there is no evidence of contaminating
wild-type virus, confirming that the stocks are clonally pure. (In
Fig. 7A, the 3.4-kb band present in the K181 track is faint but
could be clearly detected following a longer exposure of the
blot.) The recombination for KD33BT8 was confirmed in a
similar manner (data not shown), and analysis of ethidium-
stained digests (EcoRI and SacI) for the three recombinants
did not reveal any adventitious deletions elsewhere in the ge-
nome.
M33 is still transcribed in fibroblasts infected with KD33E.
To determine whether insertion of lacZ within the M33 intron
disrupted the M33 transcript for KD33E, RT-PCR was per-
formed with poly(A)1 selected RNA extracted from fibroblasts
infected 3 h previously with either wild-type or recombinant
viruses. The RT reaction was primed with MR2, and PCR was
subsequently performed across the splice junction with MF1
andMR1. As shown in Fig. 8, an RT-PCR product correspond-
ing to the spliced M33 transcript was detected in fibroblasts
infected with both K181 and KD33E, demonstrating that the
insertion of the lacZ cassette within the intron sequences of
M33 did not prevent splicing to produce the authentic M33
transcript, presumably because the transcription termination
signal of the cassette was inefficiently utilized. The intron of
M33 may therefore provide a suitable site for the expression of
heterologous genes without disrupting viral gene expression.
The KD33E recombinant was subsequently used as a control
virus recombinant to determine the effect, if any, of the ex-
pression of lacZ from the M33 region on the resulting pheno-
type in vitro and in vivo.
M33 is not required for replication in fibroblasts in vitro.
Multistep growth curves were generated to determine whether
the mutations in M33 affected the growth of the recombinant
viruses in cell culture. Primary MEF were infected at an MOI
of 0.01, and virus titers were determined from these cultures at
various times p.i. and compared with the growth of wild-type
MCMV (K181) (Fig. 9). No significant difference in replication
between the mutants and wild-type MCMV was observed, in-
dicating that M33, like UL33 (5), does not encode a function
that is important for growth in fibroblasts in vitro.
M33 is critical for growth in salivary glands in vivo. Tissue
culture-passaged MCMV (K181) is severely attenuated for
growth in vivo during the acute phase, and thus a quantitative
comparison of the replicative abilities of the recombinant vi-
ruses with wild-type MCMV is difficult. However, following a
single passage in the salivary glands of mice, wild-type MCMV
replicates to high titers in a number of target organs, particu-
larly the spleen and liver. In an attempt to generate virulent
salivary gland virus stocks of the recombinant viruses for in
vivo growth studies, 3-week-old BALB/c mice were inoculated
intraperitoneally with 104.7 PFU of either KD33BT2 or
KD33BT8 recombinant viruses. Control mice received the same
dose of tissue culture-derived wild-type K181 virus or KD33E.
During the acute stage of infection, virus was recovered from
the spleens and livers of all wild-type- and KD33E-infected
mice, although, as expected, the titers were low (102- 102.7
PFU/organ [Table 1]). In comparison, MCMV could not be
recovered from a number of KD33BT2- and KD33BT8-infected
mice, although in those which were positive, the titers were not
FIG. 7. Southern blot analysis of MCMV recombinants. DNA samples were
prepared from cells infected with either wild-type K181 or recombinant virus
(KD33BT2 or KD33E). Samples were digested with EcoRI, separated on a 0.8%
agarose gel, and blotted onto nylon membranes prior to hybridization to radio-
actively labelled probes. (A) The 5-kb BglII fragment of pINGM33 was used as
the probe; (B) the 3.8-kb lacZ cassette from pMV10 was used as the probe. The
position of DNA markers is indicated in kilobase pairs. The predicted positions
of EcoRI sites for K181 and the two recombinants are shown schematically below
the blot. Open boxes represent the 5-kb BglII region, and the hatched box
indicates the lacZ ORF, with fragment sizes indicated in kilobases.
FIG. 8. Demonstration of transcription of correctly spliced M33 transcripts
for recombinant KD33E. PCRs of DNA and RT-PCRs of poly(A)1 RNA from
MCMV-infected MEF cultures (24 h p.i.) were performed with oligonucleotides
whose specificity is shown in Fig. 1D. Cultures were infected with either K181
(lanes 1, 3, and 5) or KD33E (lanes 2, 4, and 6). Amplification of infected cellular
DNA by PCR was performed with oligonucleotide pair MF1-MR1 (lanes 1 and
2). First-strand synthesis from poly(A)1 RNA with AMV RT was performed
with oligonucleotide MR2 (lanes 3 and 4). Amplification of RT products by PCR
was performed with oligonucleotide pair MF1-MR1 (lanes 3 to 6). To confirm
that the amplified RT products were derived from RNA rather than from
contaminating genomic DNA, control RT reactions were carried out with oligo-
nucleotide MR2 in the absence of AMV RT (lanes 5 and 6). Products were
separated on a 1.8% agarose gel. The relative migration of molecular mass
markers (in base pairs) are indicated in lanes M. No products were observed in
uninfected cultures (not shown).
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significantly different from those in wild-type infected mice.
However, while mice inoculated with either wild-type MCMV
or KD33E yielded high levels of virus in the salivary glands on
day 17 p.i., MCMV was not detected in the salivary glands of
mice inoculated with the KD33B recombinants. Subsequent
experiments with higher doses of inoculum and/or harvesting
at different times p.i. also failed to elicit detectable levels of
MCMV from the salivary glands of weanling mice. In addition,
MCMV was not recovered from mice inoculated with 103.7
PFU of either KD33BT2 or KD33BT8 recombinants directly in
the salivary gland (Table 1, i.g.). These experiments indicate
that M33 is critical for growth in vivo, particularly in the dis-
semination to and replication of virus in the salivary gland.
DISCUSSION
It is now apparent that a number of different viruses from
within the herpesvirus and poxvirus families encode GCR ho-
mologs. Since cellular GCRs show considerable diversity, both
in ligand specificity and in effects upon cellular behavior fol-
lowing ligand binding, many different roles can be envisaged
for these viral GCRs. Of the GCR homologs encoded by
HCMV, US28 has attracted particular attention as a potential
chemokine receptor. In agreement with hypotheses based on
the high level of sequence homology at the N terminus of US28
to known beta-chemokine receptors, US28 has been shown to
bind beta-chemokines and to mediate cellular signalling as
measured by intracellular calcium flux (13, 24). Similarly, the
HSV GCR homolog ECRF3 has been shown to interact with
alpha-chemokines (1).
The conservation of HCMV UL33 in MCMV, HHV-6, and
HHV-7, of which homologs in the gamma- and alphaherpes-
viruses have not been identified, suggests that these gene prod-
ucts are important for the biological characteristics of betaher-
pesviruses. While preliminary analysis of these ORFs did not
show notable conservation with GCRs at their N termini, this
study has identified splicing in both the M33 and UL33 tran-
scripts which, in contrast to the unspliced products of M33 and
UL33, display an increased level of conservation with other
mammalian GCRs and known viral homologs. Predicted splic-
ing for the U12 genes of HHV-6 and HHV-7 likewise results in
a higher degree of conservation at the N termini. When the
above four sequences are aligned, it is apparent that a number
of features characteristic of chemokine receptors are con-
served, as illustrated in Fig. 6. These features include a con-
served N-terminal glycosylation site and cysteine residue, the
latter of which is invariant among the chemokine receptor
subfamily of GCRs (23). In addition, the authentic M33 N
terminus possesses two pairs of acidic residues which are also
common to chemokine receptors. Although there are no sig-
nature motifs common to all chemokine receptors, they pos-
sess, in addition to an acidic glycosylated N terminus, a short
third intracellular domain, which is enriched for basic residues.
Furthermore, in contrast to many other GCRs, the first and
fourth cysteines of the chemokine receptors, which are pre-
dicted to be disulfide linked, are highly conserved.
By analogy with US28 and ECRF3, it is tempting to specu-
late that the UL33 homologs may similarly display properties
associated with chemokine receptors which lead to activation
of the infected cell. It should be noted, however, that while
US28 and ECRF3 were both found to have a high degree of
amino acid identity at the N terminus in comparison with
known chemokine receptors (MIP-1a/RANTES and IL-8 re-
ceptors, respectively), such a high level of conservation is not
apparent for the UL33 homologs. Since the N terminus of
GCRs is significant in determining the ligand-binding capacity,
it is possible either that the UL33 homologs are not involved in
chemokine binding or that they may interact with chemokines
for which cellular receptors have yet to be determined.
Despite proving to be nonessential for growth in primary
MEF in vitro, tissue culture stocks of the M33 null MCMV
recombinants were defective in replication in vivo, in particular
in the salivary gland, which is the major site of replication and
persistence. Previous histological studies of MCMV-infected
mice have shown that serious acinar cells of the salivary gland
are the principal cells that support MCMV replication in vivo
(16, 30). As cell lines derived from the salivary gland are not
yet available, we are unable to make a direct, quantitative
comparison of the replicative ability of wild-type and KD33B
recombinants in these cells. Nevertheless, we were unable to
detect virus replication following intraglandular inoculations
with cell-free virus stocks of the KD33B recombinants. While
these results suggest that M33 directly affects MCMV replica-
tion in salivary gland cells, it is also possible, given that MCMV
infection in vivo is highly cell associated, that M33 plays a role
FIG. 9. Multistep growth curves of wild-type MCMV, KD33E, KD33BT2, and
KD33BT8 in MEF. Confluent monolayers (in 24-well trays) were infected with
0.01 PFU per cell of either K181 MCMV (), KD33E (h), KD33BT2 ({), or
KD33BT8 (E). Following virus adsorption (1 h at 378C), monolayers were
washed, fresh medium was added (2 ml per well), and the mixture was incubated
for various times prior to harvesting (cells and supernatant). Samples were stored
at 2808C prior to titer determination on MEF. Each point represents the mean
of triplicate samples; standard errors were #10% of the mean value and are not
shown.
TABLE 1. Growth of wild-type MCMV and M33
recombinant viruses in vivo
Virusa
Virus titerb in expt 1
(104.7 PFU i.p.)
Virus titerb in expt 2
(103.7 PFU i.p./i.g.)
Spleen Liver Salivarygland
Salivary
gland (i.p.)
Salivary
gland (i.g.)
Wild-type K181 2.0 6 0.2 2.7 6 0.1 7.30 6 0.2 4.9 6 0.1 4.6 6 0.4
KD33BT2 1.6 2.0 ,1.0 ,1.0 ,1.0
KD33BT8 1.3 1.8 ,1.0 ,1.0 ,1.0
KD33E 1.7 6 0.3 2.0 6 0.2 5.81 6 0.3 3.4 6 0.2 2.3 6 0.3
a In each experiment groups of three or four mice were infected with each
virus.
b In experiment 1, virus titers were determined on day 3 p.i. (for the spleen and
liver) or day 17 p.i. (for the salivary gland). In experiment 2, virus titers were
determined on day 7 p.i., following i.p. or intraglandular (i.g.) inoculation of
virus. Virus titers are expressed as the log10 6 standard error. Values without
standard errors represent the titers of a single positive sample; the titers of the
remaining samples in each group were ,1.0.
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in the trafficking of infected leukocytes or the transmission of
virus from infected leukocytes to target organs. Indeed, al-
though a quantitative assessment of the M33 null mutants
during acute infection was not possible due to the low levels of
virus replication, it is possible that there is a global in vivo
attenuation exhibited by the M33 null mutants, given that virus
was not recovered from the spleens and livers of the majority
of mice during acute infection. It is unlikely that the reduction
in MCMV replication was due to the expression of b-galacto-
sidase per se, as the KD33E recombinant, which contained
lacZ within the M33 intron was shown to be replicate to levels
comparable with wild-type MCMV.
Previous studies have identified another MCMV gene, sgg-1,
which is also important for high virus growth in the salivary
gland (18, 21). Unlike M33, homologs of sgg-1 have not been
identified in any other betaherpesviruses, suggesting that it
may encode a function of particular importance to MCMV
rather than of general significance for betaherpesviruses.
While the strict species specificity of the betaherpesviruses
prevents studies of the HCMV and HHV-6/7 GCR homologs
in the immunocompetent host, the murine model of CMV
infection provides an excellent vehicle for the expression and
characterization of betaherpesvirus genes in the context of a
natural infection. The identification of several MCMV genes
nonessential for growth in vitro have been recently reported (7,
8, 18, 21, 32) and their role in vivo characterised (7, 8, 18). The
availability of the complete nucleotide sequence for MCMV
will provide the basis for further, systematic analyses. The high
level of sequence conservation between UL33 and M33 implies
a conserved biological function which may allow the UL33
gene of HCMV to substitute for the MCMV counterpart.
Toward this end, we are developing an in vivo system for the
characterization HCMV UL33 and other betaherpesvirus
GCR homologs.
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